ONESOURCE — Onesource Specialty Pharma Income Statement
0.000.00%
Last trade - 00:00- IN₹182.12bn
- IN₹187.79bn
- IN₹1.72bn
Annual income statement for Onesource Specialty Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | ARS | ARS |
| Standards: | IAS | IAS |
| Status: | Final | Final |
| Revenue | ||
| Total Revenue | 387 | 1,719 |
| Cost of Revenue | ||
| Gross Profit | -17.8 | 813 |
| Selling / General / Administrative Expenses | ||
| Depreciation and Amortization | ||
| Unusual Expense / Income | ||
| Other Operating Expenses | ||
| Total Operating Expenses | 4,003 | 4,460 |
| Operating Profit | -3,616 | -2,741 |
| Gain / Loss on Sale of Assets | ||
| Total Net Non Operating Interest Income / Expense | ||
| Other Net Non Operating Costs | ||
| Net Income Before Taxes | -4,156 | -3,657 |
| Provision for Income Taxes | ||
| Net Income After Taxes | -4,156 | -3,657 |
| Net Income Before Extraordinary Items | ||
| Extraordinary Items | ||
| Net Income | -7,998 | -3,912 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||
| Income Available to Common Shareholders Including Extraordinary Items | ||
| Diluted Net Income | -7,998 | -3,912 |
| Diluted Weighted Average Shares | ||
| Basic EPS Including Extraordinary Items | ||
| Diluted EPS Including Extraordinary Items | ||
| Diluted EPS Excluding Extraordinary Items | ||
| Normalised Income Before Taxes | ||
| Normalised Income After Taxes | ||
| Normalised Income Available to Common Shareholders | ||
| Diluted Normalised EPS | -23.6 | -21.3 |
| Dividends per Share |